D-NEONET
cancer
ONcology
drug discovery-development
Delivery of Therapeutics
D-NET
Delivery NEtwork
ophthalmology
Development of Novel Eye Therapeutics
drug screens
non-academic partners
Eye Therapeutics Severe ocular disorders
development of novel drugs
lives
main hallmarks of severe eye conditions
ocular disease
therapeutic targets
clinical trials
interdisciplinary expertise
people world-wide
Clinical Trial Project Management Practices
European interdisciplinary consortium
ongoing FP7-IAPP project
leading cause of pre-mature mortality
e angiogenesis
vascular permeability
preclinical models
technological excellence
nanotechnology
forces
toxicology
advanced international co-operation
improvement of available treatments
pivotal roles
current therapies
exchange skills
biomaterials
ADME
tissues
synergies
biomarkers
growing demographic group
years of age
tangible innovative outputs
competitiveness
inflammation
success
fields
Enhancement of Research
vehicle
researchers
industries
countries
program
overall goal
global objectives
kind of diseases
population
participation
lifetime